DNA CHIP RESEARCH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,073 JPY | -2.63% |
|
-2.28% | +55.06% |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,848 | 3,787 | 2,219 | 4,076 | 2,519 | 4,625 |
| Enterprise Value (EV) 1 | 5,628 | 3,129 | 1,917 | 3,456 | 2,030 | 4,350 |
| P/E ratio | -46 x | -32 x | -17.3 x | -23.2 x | -18.8 x | -11.8 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 16.2 x | 10.5 x | 6.15 x | 12.6 x | 5.9 x | 14.1 x |
| EV / Revenue | 15.5 x | 8.69 x | 5.31 x | 10.7 x | 4.75 x | 13.3 x |
| EV / EBITDA | -48.1 x | -35.6 x | -18.1 x | -22.9 x | -13.4 x | -12.6 x |
| EV / FCF | -64.6 x | -31.1 x | -9.86 x | -30.4 x | -14 x | -12.7 x |
| FCF Yield | -1.55% | -3.21% | -10.1% | -3.28% | -7.16% | -7.88% |
| Price to Book | 19.9 x | 4.91 x | 3.4 x | 4.39 x | 3.23 x | 6.21 x |
| Nbr of stocks (in thousands) | 4,238 | 5,090 | 5,090 | 5,790 | 5,790 | 6,353 |
| Reference price 2 | 1,380 | 744.0 | 436.0 | 704.0 | 435.0 | 728.0 |
| Announcement Date | 6/22/18 | 6/21/19 | 6/26/20 | 6/25/21 | 6/24/22 | 6/23/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 362 | 360 | 361 | 324 | 427 | 327 |
| EBITDA 1 | -117 | -88 | -106 | -151 | -151 | -346 |
| EBIT 1 | -125 | -100 | -124 | -172 | -167 | -363 |
| Operating Margin | -34.53% | -27.78% | -34.35% | -53.09% | -39.11% | -111.01% |
| Earnings before Tax (EBT) 1 | -127 | -104 | -128 | -172 | -134 | -361 |
| Net income 1 | -127 | -104 | -128 | -172 | -134 | -362 |
| Net margin | -35.08% | -28.89% | -35.46% | -53.09% | -31.38% | -110.7% |
| EPS 2 | -29.97 | -23.22 | -25.15 | -30.30 | -23.15 | -61.70 |
| Free Cash Flow 1 | -87.12 | -100.5 | -194.5 | -113.5 | -145.4 | -342.9 |
| FCF margin | -24.07% | -27.92% | -53.88% | -35.03% | -34.05% | -104.85% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/22/18 | 6/21/19 | 6/26/20 | 6/25/21 | 6/24/22 | 6/23/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 131 | 83 | 114 | 105 | 29 | 88 | 79 | 67 | 164 | 107 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -94 | -129 | -132 | -55 | -107 | -205 | -117 | -95 | -160 | -75 |
| Operating Margin | -71.76% | -155.42% | -115.79% | -52.38% | -368.97% | -232.95% | -148.1% | -141.79% | -97.56% | -70.09% |
| Earnings before Tax (EBT) 1 | -93 | -129 | -132 | -39 | -107 | -205 | -109 | -95 | -160 | -76 |
| Net income 1 | -93 | -130 | -132 | -39 | -108 | -206 | -109 | -96 | -161 | -76 |
| Net margin | -70.99% | -156.63% | -115.79% | -37.14% | -372.41% | -234.09% | -137.97% | -143.28% | -98.17% | -71.03% |
| EPS 2 | -18.45 | -23.40 | -22.88 | -6.800 | -18.69 | -35.60 | -18.77 | -15.16 | -25.48 | -11.99 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/24/19 | 10/22/20 | 10/21/21 | 1/27/22 | 7/28/22 | 10/27/22 | 1/24/23 | 8/4/23 | 11/2/23 | 2/8/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 220 | 658 | 302 | 620 | 489 | 275 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -87.1 | -101 | -195 | -114 | -145 | -343 |
| ROE (net income / shareholders' equity) | -35.7% | -19.6% | -18% | -21.8% | -15.7% | -48.6% |
| ROA (Net income/ Total Assets) | -17.8% | -9.94% | -9.65% | -12.2% | -10.9% | -25.8% |
| Assets 1 | 712.8 | 1,047 | 1,327 | 1,410 | 1,226 | 1,405 |
| Book Value Per Share 2 | 69.40 | 151.0 | 128.0 | 161.0 | 135.0 | 117.0 |
| Cash Flow per Share 2 | 51.90 | 130.0 | 59.30 | 107.0 | 84.50 | 45.40 |
| Capex 1 | 29 | 4 | 27 | 9 | 7 | 94 |
| Capex / Sales | 8.01% | 1.11% | 7.48% | 2.78% | 1.64% | 28.75% |
| Announcement Date | 6/22/18 | 6/21/19 | 6/26/20 | 6/25/21 | 6/24/22 | 6/23/23 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +55.06% | 46.58M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- 2397 Stock
- Financials DNA Chip Research Inc.